A new three-drug combo is shaking up the fight against relapsed follicular lymphoma! In a big clinical trial, over 95% of patients saw their tumors shrink with this new therapy, and 79% had no trace of disease after treatment. It’s a huge leap from the old standard and could mean fewer chemo side effects. One patient even skipped chemo altogether thanks to this breakthrough. Major hope for those running out of options! #Health #BodyHealth #CancerResearch